Top of this page
Skip navigation, go straight to the content
UCB is listed on the Euronext Brussels (symbol: UCB)
For more investor news, go to the UCB Corporate Web site.
Lorem
UCB, Brussels, Belgium, is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders.
Employing more than 8,000 people in about 40 countries, UCB produced revenue of €3.1 billion in 2009.
U.S. headquarters is located in Atlanta, Ga.
UCB, Inc. is the U.S. affiliate of UCB S.A.
More information on Investors on the
UCB Corporate Web site.
